These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38150944)

  • 21. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
    Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
    J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
    Thorsson L; Dahlström K; Edsbäcker S; Källén A; Paulson J; Wirén JE
    Br J Clin Pharmacol; 1997 Feb; 43(2):155-61. PubMed ID: 9131947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT; Kunka RL; Yin Y; Andrews SM; Callejas S; Ng C
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved method for the determination of fluticasone propionate in human plasma.
    Laugher L; Noctor TG; Barrow A; Oxford JM; Phillips T
    J Pharm Biomed Anal; 1999 Dec; 21(4):749-58. PubMed ID: 10701940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry.
    Li YN; Tattam BN; Brown KF; Seale JP
    J Pharm Biomed Anal; 1997 Nov; 16(3):447-52. PubMed ID: 9589403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
    Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
    Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
    [No Abstract]   [Full Text] [Related]  

  • 30. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.
    Watts AM; West NP; Smith PK; Zhang P; Cripps AW; Cox AJ
    Immun Inflamm Dis; 2022 Mar; 10(3):e571. PubMed ID: 34813682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A; Bareille PJ; Rousell VM
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of triamcinolone in human plasma by a sensitive HPLC-ESI-MS/MS method: application for a pharmacokinetic study using nasal spray formulation.
    César IC; Byrro RM; de Santana e Silva Cardoso FF; Mundim IM; de Souza Teixeira L; de Sousa WC; Gomes SA; Bellorio KB; Brêtas JM; Pianetti GA
    J Mass Spectrom; 2011 Mar; 46(3):320-6. PubMed ID: 21394848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid chromatography/tandem mass spectrometry method for the quantification of deserpidine in human plasma: Application to a pharmacokinetic study.
    Zhang H; Zhong D; Zhang Z; Dai X; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3221-5. PubMed ID: 19620026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of fluticasone propionate in induced sputum by mass spectrometry.
    Hagan JB; Taylor RL; Kita H; Singh RJ
    Allergy Asthma Proc; 2011; 32(4):18-21. PubMed ID: 21781401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of inhaled fluticasone propionate via chambers/masks in young children.
    Blake K; Mehta R; Spencer T; Kunka RL; Hendeles L
    Eur Respir J; 2012 Jan; 39(1):97-103. PubMed ID: 21933835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects.
    Howland WC; Hampel FC; Martin BG; Ratner PH; van Bavel JH; Field EA
    Clin Ther; 1996; 18(6):1106-17. PubMed ID: 9001827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers.
    Borges NC; Astigarraga RB; Sverdloff CE; Borges BC; Paiva TR; Galvinas PR; Moreno RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):236-42. PubMed ID: 21233029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.